| (Values in U.S. Thousands) | Mar, 2025 | Sep, 2024 | Jun, 2024 | Mar, 2024 | Sep, 2023 |
| Sales | 103 | 190 | 19 | 110 | 298 |
| Sales Growth | -45.54% | +898.99% | -82.66% | -63.18% | -82.79% |
| Net Income | -847 | -2,055 | -976 | -1,032 | -907 |
| Net Income Growth | +58.78% | -110.47% | +5.35% | -13.72% | +26.54% |
Filament Health Corp (FH.NE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Filament Health Corp is a natural psychedelic drug development company. Its mission is to see safe, approved, natural psychedelics in the hands of everyone who needs them as soon as possible. The group engages in natural extraction technology commercialization, utilizing its intellectual property portfolio, in-house GMP facility, and Health Canada psilocybin Dealer's License.
Fiscal Year End Date: 12/31